Danaher Corporation (DHR) Receives ‘Analyst’ Rating

Danaher Corporation (DHR) : 14 analysts are covering Danaher Corporation (DHR) and their average rating on the stock is 1.61, which is read as a Buy. 9 equity analysts believe that the stock has a bright future and the price doesnt capture all of its upside, hence they rate the stock as a Strong Buy. Danaher Corporation (DHR) also receives 1 more Buy recommendations from analysts who believe that the stock will do well going forward. A Zacks Investment Research rank of 3, which recommends a Hold affirms that they expect a large upside in the stock from the current levels. A total of 4 brokerage firms believe that the stock is fairly valued, hence they advise a Hold on the stock.

Danaher Corporation (DHR) : Average target price received by Danaher Corporation (DHR) is $93.27 with an expected standard deviation of $10.31. The most aggressive target on the stock is $120, whereas the most downbeat target is $82. 11 financial analysts are currently covering the stock.


Also, Barclays maintains its view on Danaher Corporation (NYSE:DHR) according to the research report released by the firm to its investors. The shares have now been rated Overweight by the stock experts at the ratings house. Barclays raises the price target from $90 per share to $91 per share on Danaher Corporation. The rating by the firm was issued on September 7, 2016.

Danaher Corporation (NYSE:DHR): After opening at $76.62, the stock dipped to an intraday low of $76.23 on Thursday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $77.26 and the buying power remained strong till the end. The stock closed at $76.8 for the day, a gain of 0.46% for the day session. The total traded volume was 4,506,541. The stocks close on the previous trading day was $76.45.

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. The Test & Measurement segment offers test, measurement and monitoring products. The Environmental segment products and services help protect the global water supply, facilitate environmental stewardship and enhance the safety of personal data. The Companys diagnostics business offers analytical instruments, reagents, consumables, software and services. The Dental segment provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The Companys Industrial Technologies solutions help protect the worlds food supply, improve packaging design and quality, verify pharmaceutical dosages and authenticity and power innovative machines.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.